Survival Advantage for Patients With AML and MDS Given Allogeneic Hematopoietic STEM CELL Transplantation Using Myeloablative Versus Reduced Intensity Conditioning (RIC) MAY Become Apparent 5-10 YEARS After Transplantation
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2013.12.234
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2014
Authors
Publisher
Elsevier BV